Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NO-UTI: Methenamine Hippurate for Post-Operative UTI Prevention
NCT02358993Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2014
- Primary completion
- Sep 2020
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of methenamine hippurate in urinary tract infection (UTI) (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Treatment of Clinically Suspected UTI - Using Intent to Treat Analysis and Treatment of Clinically Suspected UTI - Per Protocol. Started Dec 2014; status: completed.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02358993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358993.